Skip to main content

Table 1 Descriptions of studies based on sample populations and stimulation parameters

From: Strategies to implement and monitor in-home transcranial electrical stimulation in neurological and psychiatric patient populations: a systematic review

Study Study Design and Population Stimulation Parameters
  Design Size Gender Age (years) Condition Type Target Area Electrodes Current Session Duration
Andrade 2013 Case series 1 1F 25 Schizophrenia Zeebeetronics F3 (Anodal tDCS) 25cm2 1–3 mA 3 years 20–30 min
Andre 2016 RCT 22 NS 63–94 Dementia NeuroConn DLPFC (Anodal tDCS) 35cm2 2 mA 4 sessions 20 min
Carvalho 2018 Case series 1 1F 57 Neuropathic pain Neuroelectric Starstim M1 (Anodal tDCS) 35cm2 2 mA 5 sessions 20 min
Cha 2016 RCT 24 24F 52.9 ± 12.2 MdDS Transcranial Technologies DLPFC 35cm2 1 mA 20 sessions 20 min
Charvet 2017a Observational 25 21F, 4 M 51.0 ± 12.7 MS Soterix Mini-Clinical Trials DLPFC (Anodal tDCS) 35 cm2 1.5 mA 10 sessions 20 min
Charvet 2017b1 RCT 27 16F, 11 M 44.2 MS Soterix Mini-Clinical Trials DLPFC (Anodal tDCS) 25 cm2 2 mA 20 sessions 20 min
Clayton 2018 Case series 1 1F 54 MS, Bipolar NS DLPFC (Anodal tDCS) NS 2 mA 40 sessions 20 min
Dobbs 2018 Case series 16 4F, 12 M 66.9 ± 5.4 PD Soterix Mini-Clinical Trials DLPFC (Anodal tDCS) 25cm2 2 mA 10 sessions 20 min
Hagenacker 2014 RCT - crossover 17 10F, 7 M 32–82 Trigeminal neuralgia Neuronica M1 (Anodal tDCS) 16cm2 1 mA 14 sessions 20 min
Hyvarinen 2016 Observational 43 20F, 23 M 51 ± 15.4 Tinnitus Sooma Auditory or bifrontal tDCS 35cm2 2 mA 10 sessions 20 min
Kasschau 2016 Case series 20 17F, 3 M 30–69 MS tDCS mini-Clinical Trial DLPFC 25cm2 1.5 mA 10 sessions 20 min
Loo 2017 Case series 10 NS NS Depression NS DLPFC NS 2 mA 20 sessions 30 min
Martens 2018 RCT - crossover 27 8F,19M 42 ± 14.5 MCS CEFALY tDCS DLPFC 35cm2 2 mA 20 sessions 20 min
Mortenson 2016 RCT 16 7F, 9 M 44–76 Stroke NeuroConn M1 (Anodal tDCS) 35cm2 1.5 mA 5 sessions 20 min
Riggs 2018 Case series 4 2F, 2 M 44–63 Multiple conditions Soterix Mini-Clinical Trials DLPFC/M1 (Anodal tDCS) 25cm2 1–1.5 mA 10 sessions 20 min
Schwippel 2017 Case series 1 1 M 31 Hallucinations Neuroconn Tempoproparietal (Anodal tDCS) 35cm2 2 mA 400 sessions 20 min
Sharma 2018 RCT 12 NS 64.7 ± 7.1 PD NS DLPFC NS 2 mA 10 sessions 20 min
Treister 2015 Case series 11 7F, 4 M 60.6 ± 16.3 Neurological pain NS M1 (Anodal tDCS) NS 1.5 mA 12 sessions 20 min
Van de Winckel 2018 Case series 6 3F, 3 M 61 ± 10 Stroke StartSim M1 bihemispheric 20cm2 1.5 mA 5 sessions 20 min
  1. DLPFC = Dorsolateral prefrontal cortex; F = female; M = male; MCS = Minimally conscious state; MdDS = Mal De Debarquement Syndrome; MS = Multiple sclerosis; M1 = primary motor cortex; NS = not stated; PD = Parkinson’s disease; RCT = Randomised controlled trial; tDCS = transcranial Direct Current Stimulation
  2. 1, data only reported for study two